Ignite Creation Date:
2024-05-06 @ 6:38 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05736575
Status:
RECRUITING
Last Update Posted:
2023-11-30
First Post:
2023-02-09
Brief Title:
Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients
Sponsor:
Universidad Autonoma de Madrid
Organization:
Universidad Autonoma de Madrid
Study Overview
Official Title:
Differences in Brain Derived Neurotrophic Factor Levels Between Chronic and Asymptomatic Pain Patients
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BDNF
Brief Summary:
A case-control study will be conducted to analyze the differences in BDNF levels between patients with chronic pain and asymptomatic people
Detailed Description:
Brain-derived neurotrophic factor BDNF is considered a biomarker of brain plasticity Since different alterations in brain plasticity have been found in chronic pain patients the investigators want to study whether there are differences at the molecular level in this population compared to an asymptomatic population in order to be able to accurately measure the impact of different physiotherapy interventions in an objective way
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None